top of page
gradientForSurfBreak.png

Item List

Newswire EIN
CureMatch and xCures partner to revolutionize the standard for precision cancer treatment processes

CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, is proud to announce a partnership with xCures, Inc., to connect cancer patients and physicians with optimal investigational or approved therapies. CureMatch will leverage the xCures technology platform to create a comprehensive outline of a cancer patient’s medical history and further enhance its precision cancer treatment recommendation capabilities.

Recent Posts

Portfolio Company

Carlsmed.png

Marigold Health Secures $11m in Series A Funding to Expand Peer Support
...

Busineswire

Portfolio Company

Carlsmed.png

Materna Medical Launches Groundbreaking Virtual Clinical Trial Evaluating Treatm ...

Yahoo Finance

Portfolio Company

Carlsmed.png


Clarified Precision Medicine, xCures Partner to Improve Clinical Decision Suppo ...

Precision Medicine Online

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page